Matches in Nanopublications for { ?s ?p "[Early gastric carcinomas demonstrating I-CLDN (+) phenotype have a high risk of synchronous and metachronous secondary gastric epithelial neoplasias.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- NP102096.RAeoZOZeH5atKwNx_VQA2dra1xCokQPxzuPf_1Fmpse50130_assertion description "[Early gastric carcinomas demonstrating I-CLDN (+) phenotype have a high risk of synchronous and metachronous secondary gastric epithelial neoplasias.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP102096.RAeoZOZeH5atKwNx_VQA2dra1xCokQPxzuPf_1Fmpse50130_provenance.
- NP100699.RAEgDZZRDWYJHvoER9283kg8WJpsn6nGNk95XsSQrjLSY130_assertion description "[Early gastric carcinomas demonstrating I-CLDN (+) phenotype have a high risk of synchronous and metachronous secondary gastric epithelial neoplasias.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP100699.RAEgDZZRDWYJHvoER9283kg8WJpsn6nGNk95XsSQrjLSY130_provenance.
- NP163927.RAeVzzup22_aUM_wQG279aRRPC-K0xxulAnPFHp_FRPhM130_assertion description "[Early gastric carcinomas demonstrating I-CLDN (+) phenotype have a high risk of synchronous and metachronous secondary gastric epithelial neoplasias.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP163927.RAeVzzup22_aUM_wQG279aRRPC-K0xxulAnPFHp_FRPhM130_provenance.
- NP165319.RASohgJ7NqghU4iw0FswKLU4OJ1iSlKU9UHjD4jJFQ9eU130_assertion description "[Early gastric carcinomas demonstrating I-CLDN (+) phenotype have a high risk of synchronous and metachronous secondary gastric epithelial neoplasias.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP165319.RASohgJ7NqghU4iw0FswKLU4OJ1iSlKU9UHjD4jJFQ9eU130_provenance.